| For: | Karlsen TH, Schrumpf E, Boberg KM. Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol 2007; 13(41): 5421-5431 [PMID: 17907284 DOI: 10.3748/wjg.v13.i41.5421] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i41/5421.htm |
| Number | Citing Articles |
| 1 |
Marina Alexandrova, Diana Manchorova, Tanya Dimova. Immunity at maternal–fetal interface: KIR/HLA (Allo)recognition*. Immunological Reviews 2022; 308(1) doi: 10.1111/imr.13087
|
| 2 |
Davide Roccarina, Francesca Saffioti, Matteo Rosselli, Aileen Marshall, Massimo Pinzani, Douglas Thorburn. Utility of ElastPQ point-shear wave elastography in the work-up of patients with primary sclerosing cholangitis. JHEP Reports 2023; 5(11) doi: 10.1016/j.jhepr.2023.100873
|
| 3 |
Ulrich Beuers, Gerd A. Kullak-Ublick, Thomas Pusl, Erik R. Rauws, Christian Rust. Medical Treatment of Primary Sclerosing Cholangitis: A Role for Novel Bile Acids and other (post-)Transcriptional Modulators?. Clinical Reviews in Allergy & Immunology 2009; 36(1) doi: 10.1007/s12016-008-8085-y
|
| 4 |
Jawairia Atif, Cornelia Thoeni, Gary D. Bader, Ian D. McGilvray, Sonya A. MacParland. Unraveling the Complexity of Liver Disease One Cell at a Time. Seminars in Liver Disease 2022; 42(03) doi: 10.1055/s-0042-1755272
|
| 5 |
Johannes Roksund Hov, Kirsten Muri Boberg, Tom H Karlsen. Autoantibodies in primary sclerosing cholangitis. World Journal of Gastroenterology 2008; 14(24): 3781-3791 doi: 10.3748/wjg.14.3781
|
| 6 |
Paulo Lisboa Bittencourt, Eduardo Luiz Rachid Cançado, Cláudia Alves Couto, Cynthia Levy, Gilda Porta, Antônio Eduardo Benedito Silva, Debora Raquel Benedita Terrabuio, Roberto José de Carvalho Filho, Dalton Marques Chaves, Irene Kazue Miura, Liana Codes, Luciana Costa Faria, Andreia Silva Evangelista, Alberto Queiroz Farias, Luciana Lofêgo Gonçalves, Michele Harriz, Edmundo Pessoa A Lopes Neto, Gustavo Oliveira Luz, Patrícia Oliveira, Elze Maria Gomes de Oliveira, Janaina Luz Narciso Schiavon, Tiago Seva-Pereira, Edison Roberto Parise. Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver. Arquivos de Gastroenterologia 2015; 52(suppl 1) doi: 10.1590/s0004-28032015000500002
|
| 7 |
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology 2009; 51(2) doi: 10.1016/j.jhep.2009.04.009
|
| 8 |
Tom H. Karlsen, Andre Franke, Espen Melum, Arthur Kaser, Johannes Roksund Hov, Tobias Balschun, Benedicte A. Lie, Annika Bergquist, Christoph Schramm, Tobias J. Weismüller, Daniel Gotthardt, Christian Rust, Eva E.R. Philipp, Teresa Fritz, Liesbet Henckaerts, Rinse K. Weersma, Pieter Stokkers, Cyriel Y. Ponsioen, Cisca Wijmenga, Martina Sterneck, Michael Nothnagel, Jochen Hampe, Andreas Teufel, Heiko Runz, Philip Rosenstiel, Adolf Stiehl, Severine Vermeire, Ulrich Beuers, Michael P. Manns, Erik Schrumpf, Kirsten Muri Boberg, Stefan Schreiber. Genome-Wide Association Analysis in Primary Sclerosing Cholangitis. Gastroenterology 2010; 138(3) doi: 10.1053/j.gastro.2009.11.046
|
| 9 |
Xiaojun Jiang, Annika Bergquist, Britt-Sabina Löscher, Geetha Venkatesh, Jeff E. Mold, Kristian Holm, Jon K. Laerdahl, Sigrid S. Skånland, Kimia T. Maleki, Martin Cornillet, Kjetil Taskén, Andre Franke, Tom H. Karlsen, Niklas K. Björkström, Espen Melum. A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis. Science Translational Medicine 2021; 13(582) doi: 10.1126/scitranslmed.abb0036
|
| 10 |
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach. Gastroenterology Insights 2022; 14(1) doi: 10.3390/gastroent14010002
|
| 11 |
Jochen Mattner. Genetic susceptibility to autoimmune liver disease. World Journal of Hepatology 2011; 3(1): 1-7 doi: 10.4254/wjh.v3.i1.1
|
| 12 |
Priscila Menezes Ferri, Ana Cristina Simões e Silva, Soraya Luiza Campos Silva, Diego Junior Queiroga de Aquino, Eleonora Druve Tavares Fagundes, Débora Marques de Miranda, Alexandre Rodrigues Ferreira. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/3905240
|
| 13 |
Andrea Cassinotti, Sarah Birindelli, Mario Clerici, Daria Trabattoni, Marco Lazzaroni, Sandro Ardizzone, Riccardo Colombo, Edoardo Rossi, Gabriele Bianchi Porro. HLA and Autoimmune Digestive Disease: A Clinically Oriented Review for Gastroenterologists. The American Journal of Gastroenterology 2009; 104(1) doi: 10.1038/ajg.2008.10
|
| 14 |
Alina Grama, Alexandra Mititelu, Claudia Sîrbe, Gabriel Benţa, Tudor Lucian Pop. Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1206025
|
| 15 |
Teru Kumagi, Khalid Alswat, Gideon M. Hirschfield, Jenny Heathcote. New insights into autoimmune liver diseases. Hepatology Research 2008; 38(8) doi: 10.1111/j.1872-034X.2008.00366.x
|
| 16 |
CM Hall, S Glaser, G Alpini. Comprehensive Toxicology. 2018; doi: 10.1016/B978-0-323-95488-4.01004-4
|
| 17 |
Jason B. Samarasena, Ke-Qin Hu. Hepatobiliary Manifestations of Gastrointestinal and Nutritional Disorders. Clinics in Liver Disease 2011; 15(1) doi: 10.1016/j.cld.2010.09.003
|
| 18 |
Haixia Kuang, Jian Wu, Tao Huang, Kai Yan, Xiaoyun Hu, Ying Wu, Yudi Wang, Zhihong Wu, Xiao Chen, Gaole Yuan. Bidirectional causal links between diabetes mellitus and autoimmune liver diseases: Insights from Mendelian randomization. Journal of Diabetes Investigation 2025; 16(10) doi: 10.1111/jdi.70114
|
| 19 |
Alberto Quaglia. Practical Hepatic Pathology: A Diagnostic Approach. 2011; doi: 10.1016/B978-0-443-06803-4.00027-7
|
| 20 |
Jun Li, Chaochen Zhao, Yuechun Shen. Autoimmune cholangitis and cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2012; 27(12) doi: 10.1111/j.1440-1746.2012.07287.x
|
| 21 |
Alberto Quaglia. Practical Hepatic Pathology: a Diagnostic Approach. 2018; doi: 10.1016/B978-0-323-42873-6.00027-5
|
| 22 |
Lars Aabakken. Scandinavian journal of gastroenterology – the editors-in-chief. Scandinavian Journal of Gastroenterology 2015; 50(6) doi: 10.3109/00365521.2015.1028995
|
| 23 |
Elsemieke de Vries, Ulrich Beuers. Management of cholestatic disease in 2017. Liver International 2017; 37(S1) doi: 10.1111/liv.13306
|
| 24 |
Aksana Höblinger, Frank Lammert. Genetics of biliary tract diseases: new insights into gallstone disease and biliary tract cancers. Current Opinion in Gastroenterology 2008; 24(3) doi: 10.1097/MOG.0b013e3282f79b32
|
| 25 |
Pawel Gaj, Andrzej Habior, Michal Mikula, Jerzy Ostrowski. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. BMC Medical Genetics 2008; 9(1) doi: 10.1186/1471-2350-9-81
|
| 26 |
Alpha Boubacar Conte, Fatoumata Coulibaly, Sofia Jayi, Fatima Zohra Fdili Alaoui, Hikmat Chaara, Moulay Abdelilah Melhouf. Primary sclerosing cholangitis revealed by pregnancy. Obstetrics & Gynecology International Journal 2023; 14(2) doi: 10.15406/ogij.2023.14.00695
|
| 27 |
Said Al Mamari, Roger W. Chapman, Kirsten Muri Boberg. Liver Immunology. 2014; doi: 10.1007/978-3-319-02096-9_21
|
| 28 |
Sergio Negrin Dastis, Dominique Latinne, Christine Sempoux, André P. Geubel. Ulcerative colitis associated with IgG4 cholangitis: Similar features in two HLA identical siblings. Journal of Hepatology 2009; 51(3) doi: 10.1016/j.jhep.2009.05.032
|
| 29 |
G.J. Webb, G.M. Hirschfield. Using GWAS to identify genetic predisposition in hepatic autoimmunity. Journal of Autoimmunity 2016; 66 doi: 10.1016/j.jaut.2015.08.016
|
| 30 |
Runsheng Hong, Zhixue Li, Meng Li, Yun Dai. Hepatobiliary and pancreatic manifestations in inflammatory bowel disease: an umbrella review of meta-analyses. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848241311165
|
| 31 |
Yan-Peng Li, Li-rong Zhang, Min Jia, Xiang-Jie Hu. CYP3AP1*3Allele Is Associated With Lipid-Lowering Efficacy of Simvastatin and Atorvastatin in Chinese Women. The Journal of Clinical Pharmacology 2011; 51(2) doi: 10.1177/0091270010370589
|
| 32 |
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma. 2013; doi: 10.1007/978-94-007-6473-6_10
|
| 33 |
Jonathan H. Aron, Christopher L. Bowlus. The immunobiology of primary sclerosing cholangitis. Seminars in Immunopathology 2009; 31(3) doi: 10.1007/s00281-009-0154-7
|
| 34 |
Jessica Colin Escobar, Maria Navarez Pereyra, Mohammad Ali Abbass. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Surgical Clinics of North America 2025; 105(2) doi: 10.1016/j.suc.2024.11.001
|
| 35 |
Nanda Kerkar, Tamir Miloh. Sclerosing Cholangitis: Pediatric Perspective. Current Gastroenterology Reports 2010; 12(3) doi: 10.1007/s11894-010-0104-5
|
| 36 |
Anne-Sofie H. Jensen, Henriette Ytting, Marie Winther-Sørensen, Johan Burisch, Annika Bergquist, Lise Lotte Gluud, Nicolai J. Wewer Albrechtsen. Autoimmune liver diseases and diabetes. European Journal of Gastroenterology & Hepatology 2023; 35(9) doi: 10.1097/MEG.0000000000002594
|
| 37 |
Sophie Restellini, Olivier Chazouillères, Jean‐Louis Frossard. Hepatic manifestations of inflammatory bowel diseases. Liver International 2017; 37(4) doi: 10.1111/liv.13265
|
| 38 |
Yukihiro Nakanishi, Romil Saxena. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System. Archives of Pathology & Laboratory Medicine 2015; 139(7) doi: 10.5858/arpa.2014-0229-RA
|
| 39 |
Roger Chapman, Kris Kowdley, Geoffrey McCaughan, Christian Trautwein. Genome-wide association studies in primary sclerosing cholangitis: Still more questions than answers?. Hepatology 2011; 53(6) doi: 10.1002/hep.24333
|
| 40 |
Johannes R. Hov, Ana Lleo, Carlo Selmi, Bente Woldseth, Luca Fabris, Mario Strazzabosco, Tom H. Karlsen, Pietro Invernizzi. Genetic associations in Italian primary sclerosing cholangitis: Heterogeneity across Europe defines a critical role for HLA-C. Journal of Hepatology 2010; 52(5) doi: 10.1016/j.jhep.2009.11.029
|
| 41 |
James RL Maggs, Roger W Chapman. An update on primary sclerosing cholangitis. Current Opinion in Gastroenterology 2008; 24(3) doi: 10.1097/MOG.0b013e3282f9e239
|
| 42 |
Lena Berglin, Niklas K. Björkström, Annika Bergquist. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells. Scandinavian Journal of Gastroenterology 2013; 48(6) doi: 10.3109/00365521.2013.786131
|
| 43 |
Mahmoud Mahfouz, Paul Martin, Andres F. Carrion. Hepatic Complications of Inflammatory Bowel Disease. Clinics in Liver Disease 2019; 23(2) doi: 10.1016/j.cld.2018.12.003
|
| 44 |
Emma L. Culver, Helen K. Bungay, Margaret Betts, Colm Forde, Otto Buchel, Charis Manganis, Bryan F. Warren, Fraser R. Cummings, Satish Keshav, Simon P. L. Travis, Roger W. Chapman. Prevalence and long‐term outcome of sub‐clinical primary sclerosing cholangitis in patients with ulcerative colitis. Liver International 2020; 40(11) doi: 10.1111/liv.14645
|
| 45 |
Kirsten Muri Boberg, Roger W. Chapman, Gideon M. Hirschfield, Ansgar W. Lohse, Michael P. Manns, Erik Schrumpf. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. Journal of Hepatology 2011; 54(2) doi: 10.1016/j.jhep.2010.09.002
|
| 46 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation. Gastroenterología y Hepatología (English Edition) 2019; 42(5) doi: 10.1016/j.gastre.2019.02.030
|
| 47 |
Marcel Janse, Laetitia E. Lamberts, Lude Franke, Soumya Raychaudhuri, Eva Ellinghaus, Kirsten Muri Boberg, Espen Melum, Trine Folseraas, Erik Schrumpf, Annika Bergquist, Einar Björnsson, Jingyuan Fu, Harm Jan Westra, Harry J.M. Groen, Rudolf S.N. Fehrmann, Joanna Smolonska, Leonard H. van den Berg, Roel A. Ophoff, Robert J. Porte, Tobias J. Weismüller, Jochen Wedemeyer, Christoph Schramm, Martina Sterneck, Rainer Günther, Felix Braun, Severine Vermeire, Liesbet Henckaerts, Cisca Wijmenga, Cyriel Y. Ponsioen, Stefan Schreiber, Tom H. Karlsen, Andre Franke, Rinse K. Weersma. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology 2011; 53(6) doi: 10.1002/hep.24307
|
| 48 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígado. Gastroenterología y Hepatología 2019; 42(5) doi: 10.1016/j.gastrohep.2019.02.004
|
| 49 |
Johannes R. Hov, Vasilis Kosmoliaptsis, James A. Traherne, Marita Olsson, Kirsten M. Boberg, Annika Bergquist, Erik Schrumpf, Andrew J. Bradley, Craig J. Taylor, Benedicte A. Lie, John Trowsdale, Tom H. Karlsen. Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology 2011; 53(6) doi: 10.1002/hep.24299
|
| 50 |
Gideon M. Hirschfield, Roger W. Chapman, Tom H. Karlsen, Frank Lammert, Konstantinos N. Lazaridis, Andrew L. Mason. The Genetics of Complex Cholestatic Disorders. Gastroenterology 2013; 144(7) doi: 10.1053/j.gastro.2013.03.053
|
| 51 |
C.M. Hall, S. Glaser, G. Alpini. Comprehensive Toxicology. 2018; doi: 10.1016/B978-0-12-801238-3.95660-5
|
| 52 |
E.J.C.A. Kamp, A.C. de Vries, Marco J Bruno. Encyclopedia of Gastroenterology. 2020; doi: 10.1016/B978-0-12-801238-3.65878-6
|
| 53 |
|
| 54 |
Jeong Min Cho, Jung Hun Koh, Seong Geun Kim, Soojin Lee, Yaerim Kim, Semin Cho, Kwangsoo Kim, Yong Chul Kim, Seung Seok Han, Hajeong Lee, Jung Pyo Lee, Kwon Wook Joo, Chun Soo Lim, Yon Su Kim, Dong Ki Kim, Sehoon Park. Primary sclerosing cholangitis causally affects kidney function decline: A Mendelian randomization study. Journal of Gastroenterology and Hepatology 2024; 39(1) doi: 10.1111/jgh.16355
|
| 55 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. HLA, gut microbiome and hepatic autoimmunity. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.980768
|
| 56 |
Signe Larsen, Klaus Bendtzen, Ole Haagen Nielsen. Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management. Annals of Medicine 2010; 42(2) doi: 10.3109/07853890903559724
|
| 57 |
Beata Kasztelan-Szczerbinska, Anna Rycyk-Bojarzynska, Agnieszka Szczerbinska, Halina Cichoz-Lach. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview. Nutrients 2023; 15(3) doi: 10.3390/nu15030760
|
| 58 |
Björn E Wellge, Martina Sterneck, Andreas Teufel, Christian Rust, Andre Franke, Stefan Schreiber, Thomas Berg, Rainer Günther, Wolfgang Kreisel, Christine zu Eulenburg, Felix Braun, Ulrich Beuers, Peter R Galle, Ansgar W Lohse, Christoph Schramm. Pregnancy in primary sclerosing cholangitis. Gut 2011; 60(8) doi: 10.1136/gut.2010.228924
|
| 59 |
Maria Concetta Sorrentino, Danilo Villalta, Teresa Carbone, Maria Grazia Alessio, Maria Infantino, Luigi Cinquanta, Gaia Deleonardi, Stefan Platzgummer, Maria Teresa Trevisan, Giampaola Pesce, Brunetta Porcelli, Marilina Tampoia, Antonio Antico, Ignazio Brusca, Nicola Bizzaro. Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) guidelines on the use of autoantibody tests in the diagnosis of autoimmune liver diseases. Autoimmunity Reviews 2026; 25(7) doi: 10.1016/j.autrev.2026.104093
|
| 60 |
Kazuhiko Nakamura, Tetsuhide Ito, Kazuhiro Kotoh, Eikichi Ihara, Haruei Ogino, Tsutomu Iwasa, Yoshimasa Tanaka, Yoichiro Iboshi, Ryoichi Takayanagi. Hepatopancreatobiliary manifestations of inflammatory bowel disease. Clinical Journal of Gastroenterology 2012; 5(1) doi: 10.1007/s12328-011-0282-1
|
| 61 |
Xiaojun Jiang, Tom H. Karlsen. Genetics of primary sclerosing cholangitis and pathophysiological implications. Nature Reviews Gastroenterology & Hepatology 2017; 14(5) doi: 10.1038/nrgastro.2016.154
|
| 62 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 63 |
U. Beuers, E.A.J. Rauws, P.C.J. ter Borg, H.R. van Buuren, G. Koek. Leverziekten. 2009; doi: 10.1007/978-90-313-7437-3_10
|
| 64 |
Jörg Jahnel, Peter Fickert, Cord Langner, Christoph Högenauer, Dagmar Silbert, Judith Gumhold, Andrea Fuchsbichler, Michael Trauner. Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice. Liver International 2009; 29(9) doi: 10.1111/j.1478-3231.2009.02044.x
|
| 65 |
Espen Melum, Andre Franke, Tom H Karlsen. Genome-wide association studies - A summary for the clinical gastroenterologist. World Journal of Gastroenterology 2009; 15(43): 5377-5396 doi: 10.3748/wjg.15.5377
|
| 66 |
Kwang Il Seo, Sang-Bum Kang. Hepatobiliary Manifestation of Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2019; 73(5) doi: 10.4166/kjg.2019.73.5.248
|
| 67 |
Chalermrat Bunchorntavakul, K. Rajender Reddy. Medical Therapy of Ulcerative Colitis. 2014; doi: 10.1007/978-1-4939-1677-1_41
|
| 68 |
Blair Fennimore, Emilie H. Regner, Mark E. Gerich. Primary Sclerosing Cholangitis. 2017; doi: 10.1007/978-3-319-40908-5_3
|
| 69 |
Maria C. SORRENTINO, Teresa CARBONE, Luigi CINQUANTA, Maria G. ALESSIO, Maria INFANTINO, Gaia DELEONARDI, Maria T. TREVISAN, Brunetta PORCELLI, Lucia TERZUOLI, Stefan PLATZGUMMER, Ignazio BRUSCA, Antonio ANTICO, Marilina TAMPOIA, Giampaola PESCE, Danilo VILLALTA, Nicola BIZZARO. Linee guida SIPMeL per la determinazione degli autoanticorpi nella diagnosi delle malattie autoimmuni del fegato. La Rivista Italiana della Medicina di Laboratorio 2024; 20(1) doi: 10.23736/S1825-859X.24.00226-3
|
| 70 |
Sridhar Sundaram, Vaneet Jearth. Primary Sclerosing Cholangitis: A Clinical Update. European Medical Journal 2019; doi: 10.33590/emj/10313809
|
| 71 |
Brian D. Juran, Elizabeth J. Atkinson, Erik M. Schlicht, Joseph J. Larson, David Ellinghaus, Andre Franke, Konstantinos N. Lazaridis. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis. Liver International 2011; 31(6) doi: 10.1111/j.1478-3231.2010.02420.x
|